New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Published Jun 18, 2020

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
Ovarian Cancer Treatment Sequence
NOW
PLAYING
Ovarian Cancer Treatment during the COVID-19 Pandemic
NOW
PLAYING
Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation
NOW
PLAYING
Constipation and Diarrhea: Side Effects of Ovarian Cancer Chemotherapy
NOW
PLAYING
Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19
NOW
PLAYING
PARP Inhibitor Side Effects
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.